Point-of-care manufacturing of anti-CD19 CAR-T cells using a closed production platform: Experiences of an academic in Thailand.
Luanpitpong S, Klaihmon P, Janan M, Kungwankiattichai S, Owattanapanich W, Kunacheewa C, Chanthateyanonth S, Donsakul N, U-Pratya Y, Warindpong T, Kittivorapart J, Permpikul P, Issaragrisil S.
Luanpitpong S, et al. Among authors: klaihmon p.
Mol Ther Oncol. 2024 Oct 5;32(4):200889. doi: 10.1016/j.omton.2024.200889. eCollection 2024 Dec 19.
Mol Ther Oncol. 2024.
PMID: 39507317
Free PMC article.